ARS Investment Partners, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 733020 New York, NY

Position in REGN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$28,361,093

-$6,616,319 QoQ

Shares Held

45,484

+0.5% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

of 109 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 15.609884794653064.ToString("F0")% Shared 0.ToString("F0")% None 84.39011520534694.ToString("F0")%

Healthcare · as of Jun 30, 2026

ARS Investment Partners, LLC holds $105,565,453 across 4 Biotechnology names. REGN ranks #2 (26.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	210,462	$56,134,424
2	REGN	Regeneron Pharmaceuticals, Inc. This page	45,484	$28,361,093
3	BHVN	Biohaven Ltd.	1,374,185	$20,447,872
4	HRMY	Harmony Biosciences Holdings, Inc.	17,085	$622,064

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,361,093	45,484	+0.5%	Shares	Sole	2026-07-09
2026-03-31	$34,977,412	45,270	+27.7%	Shares	Sole	2026-04-16
2025-12-31	$27,358,932	35,445	+23.2%	Shares	Sole	2026-02-05
2025-09-30	$16,175,945	28,769	+37.9%	Shares	Sole	2025-10-15
2025-06-30	$10,948,875	20,855	+222.0%	Shares	Sole	2025-08-11
2025-03-31	$4,107,907	6,477	-0.0%	Shares	Sole	2025-05-14
2024-12-31	$4,615,898	6,480	-46.1%	Shares	Sole	2025-01-16
2024-09-30	$12,635,904	12,020	+1.2%	Shares	Sole	2024-10-16
2024-06-30	$12,484,134	11,878	-1.1%	Shares	Sole	2024-07-17
2024-03-31	$11,555,654	12,006	+1400.8%	Shares	Sole	2024-05-02
2022-09-30	$551,096	800	—	Shares	Sole	2022-10-07
No filing history on record for this holder in this stock.